Skip to content
10-Q

Quarterly Report

Sabra Health Care REIT, Inc. SBRA

0001492298-25-000031

← back to feed
Filed
Aug 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 28, 2025 239.79M sh
Shares Diluted Q2 2025 · Jun 30, 2025 240.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 240.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 233.75M sh
Shares Diluted Q2 2025 · Jun 30, 2024 233.58M sh
Dividends Paid Q2 2025 · Jun 30, 2025 $142.75M
Dividends Paid Q2 2025 · Jun 30, 2024 $138.89M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $161.22M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $132.92M
Long Term Debt Q2 2025 · Jun 30, 2025 $2.48B
Cash And Equivalents Q2 2025 · Jun 30, 2025 $95.18M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $60.47M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.71B
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.7B
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.74B
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.76B
Stockholders Equity Q2 2025 · Mar 31, 2024 $2.77B
Stockholders Equity Q2 2025 · Dec 31, 2023 $2.8B
Total Liabilities Q2 2025 · Jun 30, 2025 $2.62B
Total Liabilities Q2 2025 · Dec 31, 2024 $2.56B
Total Assets Q2 2025 · Jun 30, 2025 $5.33B
Total Assets Q2 2025 · Dec 31, 2024 $5.3B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.27
Eps Diluted Q2 2025 · Jun 30, 2025 $0.44
Eps Diluted Q2 2025 · Jun 30, 2024 $0.10
Eps Diluted Q2 2025 · Jun 30, 2024 $0.22
Eps Basic Q2 2025 · Jun 30, 2025 $0.28
Eps Basic Q2 2025 · Jun 30, 2025 $0.44
Eps Basic Q2 2025 · Jun 30, 2024 $0.10
Eps Basic Q2 2025 · Jun 30, 2024 $0.22
Sga Expense Q2 2025 · Jun 30, 2025 $12.51M
Sga Expense Q2 2025 · Jun 30, 2025 $25.24M
Sga Expense Q2 2025 · Jun 30, 2024 $12.74M
Sga Expense Q2 2025 · Jun 30, 2024 $24.63M
Net Income Q2 2025 · Jun 30, 2025 $65.54M
Net Income Q2 2025 · Jun 30, 2025 $105.85M
Net Income Q2 2025 · Jun 30, 2024 $23.98M
Net Income Q2 2025 · Jun 30, 2024 $50.23M
Revenue Q2 2025 · Jun 30, 2025 $78.99M
Revenue Q2 2025 · Jun 30, 2025 $156.43M
Revenue Q2 2025 · Jun 30, 2024 $67.94M
Revenue Q2 2025 · Jun 30, 2024 $133.97M